Ergothioneine Supplementation Shows Promise in Slowing Cognitive Decline

A pilot study, conducted by researchers at the National University of Singapore and recently published in The Journal of Alzheimer’s Disease, investigated the safety and efficacy of ergothioneine supplementation in delaying cognitive decline. The primary endpoints of the study, included neurocognitive performance assessments, plasma biomarkers of neuronal damage, and safety evaluations of renal, liver, and hematological function.